Completed
A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASH
NCT04173065
- Conditions
- Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
- Locations
-
- Viking Clinical Site 105 Madison, Alabama, United States
- Viking Clinical Site 216 Glendale, Arizona, United States
- Viking Clinical Site 159 Tucson, Arizona, United States
- Viking Clinical Site 214 North Little Rock, Arkansas, United States